State & Regional Affiliates

The ASCO State/Regional Affiliate Program addresses the practical needs of practicing oncologists by offering a range of services to its State/Regional Affiliates (local oncology societies). The affiliate program includes 46 state or regional oncology groups. These groups benefit from the Society's expertise and guidance on ways to:

  • Strengthen their organizations
  • Improve policies and procedures
  • Enhance educational activities
  • Provide support to their members

Each state/regional affiliate has two voting representatives on the ASCO State Affiliate Council. These representatives serve as a bridge between the affiliate and the Association. If your affiliate has experienced a recent leadership change, please fill out the State Affiliate Council Contact form to ensure the appropriate contacts are kept informed.

Speaker Requests

If your state/regional society is interested in having an ASCO-sponsored speaker at an upcoming meeting, ASCO leadership and/or staff are available (schedule permitting) to speak on the following topics:

  • 2021 E&M Coding Changes
  • ASCO Update
  • Cancer Delivery: Tools and Resources
  • Equity, Diversity & Inclusion
  • Legislative and/or Regulatory Update
  • Payment Reform: ASCO's Patient-Centered Oncology Payment Model
  • Practice Issues/Practice Benchmarking 
  • Rural Health
  • Quality Payment Program: Education and Implementation
  • Quality Initiatives (QOPI®, QOPI Certification, Quality Training Program, CancerLinQ®)

Please feel free to request speakers on additional topics that are not listed above. After reading the guidelines, please submit a speaker request form to ASCO at least 90 days prior to the meeting.

For More Information

The 2021 State/Regional Affiliate Program is funded through the generous support of these organizations:


Logo for GlaxoSmithKline

Logo for Janssen Pharmacyclics

This list reflects commitments as of May 7, 2021.

Random Quote

"As medical professionals and as a Society, we must all continue to evolve and transform cancer care and research with each new discovery."
Julie M. Vose, MD, MBA, FASCO
ASCO President, 2015-16